homocysteine has been researched along with Graft Occlusion, Vascular in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 6 (46.15) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balogh, E; Bereczky, Z; Csapó, K; Czuriga, I; Daragó, A; Édes, I; Herceg, B; Koszegi, Z; Maros, T; Nyul, B | 1 |
Bastounis, E; Giaginis, K; Katsargyris, A; Klonaris, C; Theocharis, SE; Tsiodras, S | 1 |
Aghaie, K; Chai, H; Schultz, G; Zhou, W | 1 |
Garcia, S; Goldman, S; Larsen, GC; Littooy, F; McFalls, EO; Moritz, TE; Murray, ST; Pierpont, G; Ward, HB | 1 |
Harris, M; Jerin, M; Shammas, NW | 1 |
Amundsen, SR; Aune, S; Dregelid, E; Eide, GE; Jenssen, GL; Jonung, T; Laxdal, E; Pedersen, G; Wirsching, J | 1 |
Amundsen, SR; Aune, S; Bertz, A; Dregelid, E; Jonung, T; Laxdal, E; Nyheim, T; Pedersen, G; Wirsching, J | 1 |
Fatourou, EM; Hamilton, G; Mikhailidis, DP; Paraskevas, KI; Seifalian, AM | 1 |
Dippel, EJ; Harb, H; Jerin, M; Kapalis, M; Reddy, M; Shammas, NW; Toth, PP | 1 |
Abdelnoor, M; Arnesen, H; Berg, K; Eritsland, J; Grønseth, K; Malinow, MR; Seljeflot, I | 1 |
Baird, RN; Currie, IC; Day, A; Irvine, C; Lamont, PM; McGrath, C; Scott, J; Stansbie, D; Wilson, YG | 1 |
Bergman, SM; Morgan, SL; Tamura, T | 1 |
Daida, H; Hosoda, Y; Iwama, Y; Mokuno, H; Shimada, K; Watanabe, Y; Yamaguchi, H; Yokoi, H | 1 |
1 review(s) available for homocysteine and Graft Occlusion, Vascular
Article | Year |
---|---|
The role of established and emerging risk factors in peripheral vascular graft occlusion.
Topics: C-Reactive Protein; Cholesterol; Coronary Artery Bypass; Diabetes Mellitus; Fibrinogen; Graft Occlusion, Vascular; Homocysteine; Humans; Hypertension; Lipoprotein(a); Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Vascular Surgical Procedures | 2007 |
2 trial(s) available for homocysteine and Graft Occlusion, Vascular
Article | Year |
---|---|
Culprit coronary lesions requiring percutaneous coronary intervention after vascular surgery often arise from in-stent restenosis of bare metal stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Elective Surgical Procedures; Female; Graft Occlusion, Vascular; Homocysteine; Humans; Male; Metals; Middle Aged; Preoperative Care; Prosthesis Design; Risk Assessment; Risk Factors; Stents; Time Factors; Treatment Outcome; United States; Vascular Surgical Procedures | 2010 |
Influence of serum lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass grafting.
Topics: Aged; Chi-Square Distribution; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Fatty Acids, Omega-3; Female; Graft Occlusion, Vascular; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Odds Ratio; Prospective Studies; Vascular Patency | 1994 |
10 other study(ies) available for homocysteine and Graft Occlusion, Vascular
Article | Year |
---|---|
Plasma homocysteine levels are related to medium-term venous graft degeneration in coronary artery bypass graft patients.
Topics: Aged; Coronary Angiography; Coronary Artery Bypass; Follow-Up Studies; Graft Occlusion, Vascular; Homocysteine; Humans; Middle Aged; Risk Factors; Saphenous Vein; Treatment Outcome; Vascular Patency | 2016 |
Enhanced TLR4 endothelial cell immunohistochemical expression in symptomatic carotid atherosclerotic plaques.
Topics: Aged; Amaurosis Fugax; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Atherosclerosis; C-Reactive Protein; Carotid Arteries; Carotid Stenosis; Endarterectomy, Carotid; Endothelial Cells; Female; Graft Occlusion, Vascular; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Ischemic Attack, Transient; Male; Stroke; Thrombosis; Toll-Like Receptor 4 | 2010 |
In vivo assessment of the effects of ginsenoside Rb1 on intimal hyperplasia in ApoE knockout mice.
Topics: Animals; Carotid Artery Injuries; Ginsenosides; Graft Occlusion, Vascular; Homocysteine; Hyperplasia; Mice; Mice, Knockout; Phytotherapy; Plant Extracts; Tunica Intima; Ultrasonography | 2010 |
Elevated levels of low-density lipoprotein cholesterol, homocysteine, and lipoprotein(a) are associated with the occurrence of symptomatic bypass graft disease 1 year following coronary artery bypass graft surgery.
Topics: Aged; Angiography; Cholesterol, LDL; Coronary Artery Bypass; Female; Follow-Up Studies; Graft Occlusion, Vascular; Homocysteine; Humans; Iowa; Lipoprotein(a); Male; Medical Records; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors | 2004 |
Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoro-popliteal artery.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Arterial Occlusive Diseases; Biomarkers; Female; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Graft Occlusion, Vascular; Hemostasis; Homocysteine; Humans; Knee; Limb Salvage; Male; Middle Aged; Multivariate Analysis; Norway; Popliteal Artery; Prospective Studies; Reoperation; Risk Factors; Statistics as Topic; Treatment Outcome; Vascular Patency; Vascular Surgical Procedures | 2004 |
Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the common iliac arteries.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Atherosclerosis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Graft Occlusion, Vascular; Hemostasis; Homocysteine; Humans; Iliac Artery; Male; Middle Aged; Multivariate Analysis; Risk Factors; Stents; Treatment Outcome; Vascular Patency; Vascular Surgical Procedures | 2006 |
Elevated levels of homocysteine predict cardiovascular death, nonfatal myocardial infarction, and symptomatic bypass graft disease at 2-year follow-up following coronary artery bypass surgery.
Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Female; Follow-Up Studies; Graft Occlusion, Vascular; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Treatment Outcome | 2008 |
Hyperhomocysteinaemia is a risk factor for vein graft stenosis.
Topics: Adult; Aged; Arterial Occlusive Diseases; Carbon Monoxide; Case-Control Studies; Constriction, Pathologic; Diabetes Complications; Disease Susceptibility; Female; Follow-Up Studies; Graft Occlusion, Vascular; Graft Survival; Homocysteine; Humans; Hyperplasia; Inguinal Canal; Leg; Male; Middle Aged; Phlebotomy; Risk Factors; Single-Blind Method; Smoking; Tunica Intima; Ultrasonography, Doppler, Duplex; Vascular Patency; Veins | 1996 |
Homocysteine, B vitamins, and vascular-access thrombosis in patients treated with hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis; Erythrocytes; Female; Folic Acid; Genotype; Graft Occlusion, Vascular; Homocysteine; Humans; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Middle Aged; Pyridoxine; Renal Dialysis; Risk Factors; Thrombophilia; Vitamin B 12 | 1998 |
Relationship between plasma homocysteine levels and saphenous vein graft disease after coronary artery bypass grafts.
Topics: Case-Control Studies; Coronary Angiography; Coronary Artery Bypass; Female; Graft Occlusion, Vascular; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Regression Analysis; Risk Factors; Saphenous Vein; Time Factors | 2001 |